Goldman Sachs lowered the firm’s price target on Canadian Solar (CSIQ) to $11 from $17 and keeps a Sell rating on the shares. Canadian Solar’s Q4 results missed guidance due to project delays and impairment charges, and Q1 guidance came in weaker than expected amid tight supply of OBBBA-compliant solar cells, seasonal softness, and higher input costs, with 2026 shipment guidance deferred, the analyst tells investors in a research note. However, the company is expanding U.S. capacity, targeting 10 GWp of module capacity by 2H26 and 6.3 GWp of domestic solar cell capacity by year-end, positioning it to operate the only commercial-scale HJT solar cell facility in the U.S., the firm says.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CSIQ:
- Midday Fly By: Micron reports Q2 beat, Uber invests in Rivian
- Morning Movers: Canadian Solar sinks following fourth quarter results
- Canadian Solar down 20% at $14.90 after Q4 results and below-consensus guide
- Canadian Solar Posts Q4 Loss but Ramps Up U.S. Manufacturing and Energy Storage Backlog
- Canadian Solar sees Q1 revenue $900M-$1.1B, consensus $1.55B
